mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.8 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.8 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0068 |
0.8 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.8 |
mRNA |
KIN001-135 |
GDSC1000 |
pan-cancer |
AAC |
-0.011 |
0.9 |
mRNA |
S-Trityl-L-cysteine |
FIMM |
pan-cancer |
AAC |
-0.033 |
0.9 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
mRNA |
Bortezomib |
FIMM |
pan-cancer |
AAC |
-0.027 |
0.9 |